DEFEAT-COVID Study : Targeting de novo Pyrimidine Biosynthesis by leflunomide as a Novel Concept for the Treatment of Corona Virus Disease 2019 (COVID-19) - DEFEAT- Covid Study

Medienart:

Klinische Studie

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

WHO International Clinical Trials Registry Platform - (2020) vom: 03. Aug. Zur Gesamtaufnahme - year:2020

Sprache:

Unbestimmt

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Confirmed Covid-19 infection by RT-PCR
Phase: Phase 2
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 09-07-2020, Last updated: 2022-11-24

ICTRP ID:

EUCTR2020-002952-18-GB
Protocol
TBC

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG006629148